AMGN Stock Price, Chart, Stats & News

Amgen Inc.
Save
AMGN chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 70.49% |
Operating margin | 27.99% |
Pretax margin | 24.41% |
Net margin | 20.97% |
Effective tax rate | 14.09% |
ROA | 8.51% |
ROE | 96.65% |
D/E | 6.31x |
Interest coverage ratio | 3.72x |
AMGN valuation
P/E | 24.15x |
P/S | 5.11x |
P/B | 21.71x |
P/CF | 18.88x |
P/FCF | 23.21x |
P/OCF | 18.88x |
PEG | 2.44x |
EV multiple | 7.63x |
About
Amgen Inc., established in 1980 and headquartered in Thousand Oaks, California, is a global biotechnology leader focused on discovering, developing, manufacturing, and delivering groundbreaking human medicines. The company's scientific endeavors span several critical therapeutic categories, including inflammatory conditions, oncology and hematology, bone health, cardiovascular diseases, nephrology, and neuroscience. Its extensive portfolio features a range of significant pharmaceutical products.
Similar securities
Based on sector and market capitalization
Report issue











